Over 100 presentations will be given at the 2019 US series. Over two days discover more about novel research and development trends, explore business and commercialisation strategies, and discover how to translate findings into viable products through collaborative partnerships and funding opportunities. With a focus on metabolic functioning, autoimmune and inflammatory disorders, the gut-brain axis and the relationship between the microbiome and cancer, explore the composition of the gut microbiome, and the tools and technologies used to study microbial communities. This meeting has a reputation for providing an outstanding networking experience in which new collaborations between industry and academia are forged to better translate research into clinical trials. Plus, you will have ample opportunity to review more than 40 poster presentations and meet with 30+ exhibitors showcasing the latest products and services.